HPE HPE Fresenius Kabi handbook - Page 21

Product name INN/active substance Therapeutic area Marketing authorisation holder Marketing authorisation date Blitzima Rituximab Non-Hodgkin lymphoma, chronic B-cell lymphocytic leukaemia Celltrion 13/07/2017 Ritemvia Rituxumab Wegener granulomatosis, microscopic polyangiitis, non-Hodgkin lymphoma Celltrion 13/07/2017 Rituzena (previously Tuxella) Rituxumab Wegener granulomatosis, microscopic polyangiitism non-Hodgkin lymphoma, chronic B-cell lymphocytic leukaemia Celltrion 13/07/2017 Insulin lispro Sanofi Insulin lispro Diabetes mellitus Sanofi Aventis 19/07/2017 Imraldi Adalimumab Ankylosing spondylitis, arthritis, Crohn’s disease, hidradenitis suppurativa, psoriatic arthritis, psoriasis, rheumatoid arthritis, ulcerative colitis, uveitis Samsung Bioepis 24/08/2017 Cyltezo Adalimumab Crohn’s disease, hidradenitis suppurativa, juvenile idiopathic arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, uveitis Boehringer Ingelheim 10/11/2017 Ontruzant Trastuzumab Early breast cancer, metastatic breast cancer, metastatic gastric cancer Samsung Bioepis 15/11/2017 Mvasi Bevacizumab Breast neoplasms, fallopian tube neoplasms, non-small-cell lung carcinoma, ovarian neoplasms, peritoneal neoplasms, renal cell carcinoma Amgen 15/01/2018 Herzuma Trastuzumab Early breast cancer, metastatic breast cancer, metastatic gastric cancer Celltrion Healthcare 09/02/2018 Semglee Insulin glargine Diabetes mellitus Mylan 28/03/2018 Kanjinti Trastuzumab Early breast cancer, metastatic breast cancer, metastatic gastric cancer Amgen 16/05/2018 Zessly Infliximab Ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, ulcerative colitis Sandoz 18/05/2018 Halimatoz Adalimumab Ankylosing spondylitis, hidradenitis suppurativa, juvenile rheumatoid arthritis, psoriatic arthritis, psoriasis, rheumatoid arthritis, uveitis Sandoz 26/07/2018 hospitalpharmacyeurope.com | 2019 | 21